News
Elon Musk’s Neuralink targets human trials for brain-machine interface in 2020
After operating in stealth mode for the past two years, Neuralink, the brain-machine interface startup co-founded by SpaceX and Tesla CEO Elon Musk, has revealed some of the innovations that it has been developing. The company also announced that it is aiming to start implanting devices in humans by 2020, starting with paralyzed individuals who could then control phones or computers through their brain-machine implants.
Neuralink focused on two innovations on Tuesday’s presentation. The first involved flexible “threads” that are incredibly thin, measuring between 4 and 6 μm or about 1/3 the diameter of human hair. These threads are capable of transferring high volumes of data, with a white paper published by the company hinting at “as many as 3,072 electrodes per array distributed across 96 threads.” With the threads being incredibly thin, they would not damage the brain.
Another key technology revealed by Neuralink on its recent presentation was a custom made robot designed to embed implants into the brain. Thanks to computer vision and lenses, the robot will be able to place implants on patients without hitting or damaging blood vessels, reducing damage to the brain and scar tissue. Neuralink researcher Philip Sabes noted that “because these things are so thin and flexible, the idea is that they move with the tissue instead of tearing the tissue.”
Neuralink has performed at least 19 surgeries on animals with its robots, and so far, the machines have successfully placed the threads about 87% of the time. One of these subjects, a rather hefty rat that was shown off to the press, was fitted with a wired prototype of the company’s brain-machine interface. During the press demo, Sabes mentioned that the amount of data gathered from the rodent was about ten times greater than what is possible with today’s sensors.
In his presentation, Elon Musk stated that the evolution of Neuralink’s tech would be gradual, though he did mention that the company’s goal is a form of “symbiosis” with technology. “It’s not going to be suddenly Neuralink will have this neural lace and start taking over people’s brains. This is going to sound pretty weird, but ultimately, we will achieve symbiosis with artificial intelligence. This is not a mandatory thing. It is a thing you can choose to have if you want. This is something that I think will be really important on a civilization-level scale,” he remarked.
While the technologies shared by Neuralink on Tuesday seemed borderline science fiction, Neuralink president Max Hodak noted that similar innovations have actually been introduced and implemented in the past. “Neuralink didn’t come out of nowhere; there’s a long history of academic research here. We’re, in the greatest sense, building on the shoulders of giants,” he said. Nevertheless, Neuralink’s goal of directly reading neural spikes in a minimally-intrusive way remains notably ambitious.
The potential for such technologies is enormous. Implants such as BrainGate, which was developed initially at Brown University, were used in cases such as those of Matthew Nagle, who suffered from a spinal cord injury. Back in 2006, Nagle was able to learn how to use a computer using brain implants, at one point even playing Pong with his mind. In its presentation, Neuralink noted that its brain implants could be used for several individuals afflicted by Parkinson’s Disease, Dystonia, Epilepsy, OCD, Depression, Chronic Pain, and Tinnitus, among many.
Yet, despite its impressive innovations and its lofty goals, it should be noted that Neuralink is still a long way from achieving its targets. Dr. Matthew MacDougall, head surgeon at Neuralink, mentioned this while discussing how Neuralink implants could be as seamless as Lasik in the future. “There is a whole FDA process we have to go though. We haven’t done that yet,” he said.
So why the presentation? As noted by Elon Musk, Tuesday’s event is, at its core, an invitation for interested individuals who would like to work on the innovations that Neuralink is pursuing. With this open invitation, it would not be surprising if the company attracts an impressive number of talent in the near future. But now it’s time for you to vote. Will you be open to getting a brain-machine interface implant from Neuralink in the future?
-
In a new note to investors on Tuesday, Morgan Stanley analyst Andrew Percoco said that Tesla has one big financial question to answer for investors regarding its Robotaxi rollout, Full Self-Driving software, and Optimus.
Percoco said in the note that, for the most part, investors are still very positive about the direction the company is headed. However, there are some things the firm would like to see, and they have to do with financials.
Tesla (TSLA) Q2 2026 earnings results: miss on EPS, beat on revenue
Tesla bulls are more than convinced that the company’s Full Self-Driving software is proof it can develop physical AI. Financially, however, there are still some questions, especially on elevated spending, which CEO Elon Musk said would occur as the company works to roll out Robotaxi faster and continue developing its Optimus robot.
The latter two are where Tesla will have to prove progress to investors, as Percoco writes that both projects “will require clearer evidence that Robotaxi is scaling and more tangible Optimus proof points to support the ROI on elevated capex.”
Percoco said the second quarter earnings call did not change his long-term thesis of where Tesla is positioned in the AI race, which is out in front. However, there are concerns that weaker gross margins and higher R&D spend will stress financials, and that has “sharpened our (and investors’) focus on measurable progress across Robotaxi and Optimus.”
Additionally, Robotaxi still needs to be proven with more operation in existing cities while maintaining safety but improving how many rides it gives in any given time, he said. For Optimus, Percoco wrote that he is “still looking for evidence beyond commentary around SOP.”
Morgan Stanley put Percoco in charge of covering Tesla after long-time analyst Adam Jonas transitioned to the automotive side.
Currently, Morgan Stanley has a $415 price target on Tesla and a ‘Hold’ rating on the stock. It is trading at around $330 at the time of publication, which was 2:30 P.M. on the East Coast.
SpaceX’s massive investment in AI will make it a big winner, Argus Research said after the company’s successful earnings call last week.
The firm also upgraded shares to a Buy from Hold and set a $160 price target.
SpaceX (NASDAQ: SPCX) is currently recovering from its heavy AI infrastructure investments, as it spent nearly $16 billion in Q2 alone. The company did this primarily by monetizing high-demand GPU compute capacity at a much faster pace than traditional data center economics would suggest.
Company CFO Bret Johnsen said that SpaceX would be able to pay back anything on new deployments within a year.
There are plenty of ways the company can do this:
Leasing excess compute capacity through contracts
SpaceX has already built Colossus and Colossus II, largely for its own model training. However, much of that capacity is already rented out to third parties. It already has major deals with Anthropic, Google, and Reflection AI. These partnerships are adding billions per month to SpaceX’s spreadsheet.
High utilization driven by industry-wide scarcity
The demand for advanced AI training and inference capacity continues to exceed what is available for use. SpaceX can fill new racks quickly after they come online, so the capital deployed converts into revenue with minimal idle time.
Additionally, management and outside observers have described the new compute capital as behaving more like a cost-of-goods-sold than traditional multi-year capex, especially because of this rapid monetization pattern.
Capacity has already scaled from ~0.4 GW a year to 1.4 GW annually by the end of Q2. There are targets of more than 2 GW by year-end.
High incremental margins on the rental business once capacity is online
GPU cloud providers often operate at strong gross margins. SpaceX can monetize capacity that was already partially built or can be added efficiently. This means that incremental EBITDA margins on the rental revenue are usually high. This accelerates cash recovery relative to the gross capital outlay.
Parallel monetization of its own AI software and applications
Beyond pure infrastructure rental, SpaceX also generates revenue from Grok through subscriptions and usage, from X through ads, data, and other related services, enterprise APIs, and the planned integration of the Cursor coding tools acquisition.
These application layers ride on the same compute infrastructure and provide additional high-margin streams that could offset build-out costs. AI-segment revenue overall rose sharply to about $2.6 billion in Q2, according to Motley Fool. This was driven primarily by the infrastructure contracts, but the software side is also partially responsible.
Efficient, large-scale deployment and vertical integration advantages
SpaceX has emphasized the rapid construction of power and cooling infrastructure and favorable cost-per-megawatt economics relative to industry benchmarks in some disclosures.
Combined with its ability to scale capacity aggressively and the fact that many contracts start generating revenue within months of capacity coming online, the effective payback compresses dramatically compared with more conventional multi-year data-center projects.
SpaceX’s dominant near-term recovery path will turn the AI clusters into a hyperscale-style compute rental business for other leading AI companies while still using a portion for internal models.
Tesla headlights have caused a recall of over 20,000 of the company’s two most popular vehicles, the Model 3 and Model Y, due to the low-beam bulb exceeding the maximum allowed intensity according to federal standards.
Tesla initiated the recall with the National Highway Traffic Safety Administration (NHTSA) this morning, stating that the low-beam output “exceeds the maximum allowed intensity in the outer upper-right and outer upper-left areas of the 10U and 90U zone, as prescribed in FMVSS No. 108.”
Tesla sourced the impacted headlights from Marelli Automotive Lighting, a Mexico-based company. The recall impacts 2020-2023 Model Y vehicles and 2017-2023 Model 3 vehicles. It is estimated that every VIN in this recall is impacted by the defect.
🚨 Tesla is recalling 20,349 2020-23 Model Y vehicles and 2017-23 Model 3 vehicles due to an excessively bright headlamp low beam.
Currently, there is no remedy plan in place, as it is still being developed. pic.twitter.com/y34cIO2U0B
— TESLARATI (@Teslarati) August 11, 2026
Typically, Tesla would remedy recalls of this nature through an Over-the-Air software update, which has been a major focus of criticism by the company and its supporters because the NHTSA still refers to it as a “recall,” even though it requires no action by the vehicle owner. The fix is shipped over the internet and downloaded to the car.
However, there appears to be a potentially different solution for this problem. Tesla has not developed a remedy for this issue, so it could potentially be on the way. The big issue appears to be the fact that these recalled lamps are out of production, and this is an old body style for both vehicles. The headlights and front-end designs are completely different.
Tesla switched to another supplier when the affected headlight design was discontinued. It plans to begin notifying owners of their remedy options by September 15.
Tesla filed a petition protesting the recall to fix the vehicles’ headlight issue, but the NHTSA denied it. Now, Tesla will come up with a solution to fix it.
Tesla has one big financial question to answer for investors: Morgan Stanley
SpaceX AI investment gamble will make it a big winner, firm says
